Regulatory T-cells (Tregs) Market to Observe Significant Growth by 2034 Owing to the Development in 12+ Indications with Severe and Refractory Patients as the Treatment Addressable Population | DelveInsight

The landscape of the Treg therapy market is expected to evolve as companies worldwide actively develop new regulatory T-cell therapies to address a diverse range of conditions, including SLE, Lupus Nephritis, Atopic Dermatitis, Rheumatoid Arthritis, Psoriasis, Progressive Multiple…